For decades, the blood thinner heparin has been used to prevent and treat blood clots. Could it be just as effective in treating cancer? In an editorial published Feb. 15 in the New England Journal of ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Early treatment with low-molecular-weight heparin (LMWH) reduces the risk for death in patients ...
New research reveals that patients receiving heparin therapy were diagnosed with Alzheimer's disease up to two years later, suggesting a possible protective effect of this common anticoagulant. Study: ...
Therapeutic-dose heparin appears to benefit noncritically-ill COVID-19 patients, but it does not reduce deaths or other adverse endpoints compared with usual-care thromboprophylaxis if it’s initiated ...
Heparin is typically administered for blood clotting, but its anti-inflammatory and anti-viral effects have captured interest as a potential COVID-19 treatment. An international team of researchers ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Heparin ...
Researchers at the Spanish National Research Council (CSIC) Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) have discovered and synthesized a number of molecules that inhibit the effects of ...
Phase II study of the insulin-like growth factor-1 receptor (IGF-1R) antibody cixutumumab (C) in patients (pts) with thymoma (T) and thymic carcinoma (TC). Background: Approximately one third of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback